日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab

平衡早期阿尔茨海默病治疗的获益与风险:欧洲药品管理局 (EMA) 对 lecanemab 和 donanemab 的评估

Guizzaro, Lorenzo; Bałkowiec-Iskra, Ewa; Haberkamp, Marion; Mol, Peter G M; Moreau, Alexandre; Mueller-Berghaus, Jan; Philadelphy, Daniela; Balabanov, Pavel; Garcia, Juan; Thirstrup, Steffen; Sepodes, Bruno

Biomarkers for neurodegenerative diseases in regulatory decision-making by the European Medicines Agency

欧洲药品管理局在监管决策中对神经退行性疾病生物标志物的使用

Hermans, Audrey M M; Bakker, Elisabeth; Starokozhko, Viktoriia; den Otter, Loes; Elferink, André J A; Bradshaw, Angela; Guizzaro, Lorenzo; Mol, Peter G M; Pasmooij, Anna M G

A model structure for describing uncertainties in benefit-risk assessment of oncology drug applications

用于描述肿瘤药物申请获益风险评估中不确定性的模型结构

Zafiropoulos, Nikolaos; Pignatti, Francesco; Kouroumalis, Andreas; Guizzaro, Lorenzo; Karres, Dominik; Demolis, Pierre; Tenhunen, Olli; Janssens, Rosanne; Taams, Anne; Bloem, Lourens T; Koenig, Franz; Posch, Martin

A review of psychedelics trials completed in depression, informed by European regulatory perspectives

结合欧洲监管视角,对已完成的迷幻药治疗抑郁症的试验进行回顾

Silva, Francisca; Butlen-Ducuing, Florence; Guizzaro, Lorenzo; Balabanov, Pavel

Estimands in CNS trials - A review of strategies for addressing intercurrent events

中枢神经系统试验中的估计量——应对并发症的策略综述

Mészáros, Lisa; Lasch, Florian; Delafont, Bruno; Guizzaro, Lorenzo

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system

一项横断面研究旨在开发并描述一种用于衡量公共医疗保健系统中癌症经济负担的患者自评量表(PROFFIT)的心理测量学特征。

Riva, Silvia; Arenare, Laura; Di Maio, Massimo; Efficace, Fabio; Montesarchio, Vincenzo; Frontini, Luciano; Giannarelli, Diana; Bryce, Jane; Del Campo, Laura; De Lorenzo, Francesco; Iannelli, Elisabetta; Traclò, Francesca; Gitto, Lara; Jommi, Claudio; Vaccaro, Concetta Maria; Barberio, Daniela; Cinieri, Saverio; Porta, Camillo; Del Mastro, Lucia; Zagonel, Vittorina; Cogoni, Alessio Aligi; Bordonaro, Roberto; Gimigliano, Anna; Piccirillo, Maria Carmela; Guizzaro, Lorenzo; Gallo, Ciro; Perrone, Francesco

The opportunity of patient-journey studies for academic clinical research in oncology

患者历程研究在肿瘤学学术临床研究中的机遇

Perrone, Francesco; Di Liello, Raimondo; Gargiulo, Piera; Arenare, Laura; Guizzaro, Lorenzo; Chiodini, Paolo; Gallo, Ciro; Piccirillo, Maria Carmela

Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study

COVID-19 对正在进行的临床试验的潜在影响:一项基于 CANNA-TICS 研究的耶鲁全球抽动严重程度量表神经系统评估模拟研究

Lasch, Florian; Guizzaro, Lorenzo; Aguirre Dávila, Lukas; Müller-Vahl, Kirsten; Koch, Armin

Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease

静息状态下皮层脑电图节律与轻度认知障碍和阿尔茨海默病患者的灰质体积相关

Babiloni, Claudio; Carducci, Filippo; Lizio, Roberta; Vecchio, Fabrizio; Baglieri, Annalisa; Bernardini, Silvia; Cavedo, Enrica; Bozzao, Alessandro; Buttinelli, Carla; Esposito, Fabrizio; Giubilei, Franco; Guizzaro, Antonio; Marino, Silvia; Montella, Patrizia; Quattrocchi, Carlo C; Redolfi, Alberto; Soricelli, Andrea; Tedeschi, Gioacchino; Ferri, Raffaele; Rossi-Fedele, Giancarlo; Ursini, Francesca; Scrascia, Federica; Vernieri, Fabrizio; Pedersen, Torleif Jan; Hardemark, Hans-Goran; Rossini, Paolo M; Frisoni, Giovanni B